Gender-Specific Interactions in a Visual Object Recognition Task in Persons with Opioid Use Disorder
- PMID: 37760905
- PMCID: PMC10525754
- DOI: 10.3390/biomedicines11092460
Gender-Specific Interactions in a Visual Object Recognition Task in Persons with Opioid Use Disorder
Abstract
Opioid use disorder (OUD)-associated overdose deaths have reached epidemic proportions worldwide over the past two decades, with death rates for men reported at twice the rate for women. Using a controlled, cross-sectional, age-matched (18-56 y) design to better understand the cognitive neuroscience of OUD, we evaluated the electroencephalographic (EEG) responses of male and female participants with OUD vs. age- and gender-matched non-OUD controls during a simple visual object recognition Go/No-Go task. Overall, women had significantly slower reaction times (RTs) than men. In addition, EEG N200 and P300 event-related potential (ERP) amplitudes for non-OUD controls were significantly larger for men, while their latencies were significantly shorter than for women. However, while N200 and P300 amplitudes were not significantly affected by OUD for either men or women in this task, latencies were also affected differentially in men vs. women with OUD. Accordingly, for both N200 and P300, male OUD participants exhibited longer latencies while female OUD participants exhibited shorter ones than in non-OUD controls. Additionally, robust oscillations were found in all participants during a feedback message associated with performance in the task. Although alpha and beta power during the feedback message were significantly greater for men than women overall, both alpha and beta oscillations exhibited significantly lower power in all participants with OUD. Taken together, these findings suggest important gender by OUD differences in cognitive processing and reflection of performance in this simple visual task.
Keywords: alpha and beta brain oscillations; electroencephalogram (EEG); event-related potentials (ERP); gender-specific differences; opioid use disorder (OUD); substance use disorder (SUD); visual attention; visual cognitive processing; visual evoked potential (VEP).
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures




Similar articles
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
Cited by
-
The Role of Dopamine in Neurological, Psychiatric, and Metabolic Disorders and Cancer: A Complex Web of Interactions.Biomedicines. 2025 Feb 17;13(2):492. doi: 10.3390/biomedicines13020492. Biomedicines. 2025. PMID: 40002905 Free PMC article.
References
-
- American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders—Fourth Edition (DSM-IV) American Psychiatric Association; Washington, DC, USA: 1994. p. 886.
-
- American Psychiatric Association (APA) DSM-5 Development: Substance Related Disorders. [(accessed on 20 February 2012)]. Available online: http://www.dsm5.org/ProposedRevisions/Pages/Substance-RelatedDisorders.aspx.
-
- American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders—Fifth Edition (DSM-5) American Psychiatric Publishing; Arlington, VA, USA: 2013. p. 947.
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous